Continuous Renal Replacement Therapy, Impact on Intensive Care Unit Length of Stay (NCT07586059) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Continuous Renal Replacement Therapy, Impact on Intensive Care Unit Length of Stay
500,000 participantsStarted 2026-08-01
Plain-language summary
This large national cohort study, including over 500,000 patients, where around 5% are treated with continuous renal replacement therapy (CRRT) , aims to evaluate the association between time to initiation of CRRT and intensive care unit (ICU) length of stay (LOS).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with critical illness
* Admitted to Swedish ICUs from 2010-2023
* Adult (18 years or older)
Exclusion Criteria:
\*Patients under 18 years of age
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is studying whether continuous renal replacement therapy (CRRT) affects how long patients stay in the ICU — can you explain what CRRT actually involves day-to-day, and how it's different from regular dialysis I might already know about?
2Since this trial isn't recruiting yet, what does that mean for my timeline — should I be exploring other options now, and would I still be a candidate once it opens?
3The trial is measuring ICU length of stay in hours as its main outcome, but I want to understand what that means for me personally — does a shorter ICU stay necessarily translate to better recovery for someone with acute kidney injury?
4Given that this study doesn't have a traditional phase number, what does that tell us about how much is already known about the safety and effectiveness of CRRT for critically ill patients like me?
5Would standard treatment for my acute kidney injury already include CRRT, or is participating in this trial the main way I'd have access to it — and how would you weigh those two paths for my situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Intensive care unit (ICU) length of stay (LOS) measured in hours
Timeframe: ICU LOS during the study period, from admission to discharge, average 168 hours (one week)